Turning Quality Into a Competitive Advantage: How Leading CMOs Use Quality Intelligence to Win and Retain Sponsors

Live on Wednesday, July 9 at 8 AM PST

Sponsors are already evaluating your organization using public regulatory data. The question is: what exactly are they looking at?

Today, sponsors increasingly use external regulatory intelligence—including FDA 483s, Establishment Inspection Reports (EIRs), warning letters, recalls, and import alerts—to assess and monitor manufacturing partners. Yet many CMOs have limited visibility into that data.

In this webinar, we'll explore how CMOs can close that visibility gap using the same transparent, standardized regulatory intelligence their sponsors rely on. Learn how quality and compliance teams can identify emerging risk signals, prioritize remediation efforts based on severity and topic, and focus scarce resources before issues escalate into compliance events.

We'll also discuss how independent benchmarking can help transform quality from a compliance function into a competitive advantage, providing objective evidence of quality standing that can strengthen sponsor conversations, support RFPs, and differentiate your organization in a crowded market.

In this webinar, you will learn:

• How sponsors use public data to evaluate and monitor CMOs
• Why most CMOs face a visibility gap in understanding their own quality profile
• How to identify and prioritize risk signals by topic and criticality
• How independent benchmarking can support sponsor audits, RFPs, and commercial growth

Designed for Quality, Compliance, Regulatory Affairs, and Business Development leaders at CMOs, this session will show how greater visibility into your external quality profile can help you better manage risk, demonstrate performance, and see your organization the way your customers already do.